Evidence map›Paper›PMID 30097540›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection.

Shalley N Kudalkar, Jagadish Beloor, Elias Quijano, Krasimir A Spasov, Won-Gil Lee, José A Cisneros, W Mark Saltzman, Priti Kumar, William L Jorgensen, Karen S Anderson

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Shalley N KudalkarDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066.
Jagadish BeloorDepartment of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520.
Elias QuijanoDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
Krasimir A SpasovDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066.
Won-Gil LeeDepartment of Chemistry, Yale University, New Haven, CT 06520-8107.
José A CisnerosDepartment of Chemistry, Yale University, New Haven, CT 06520-8107.
W Mark SaltzmanDepartment of Biomedical Engineering, Yale University, New Haven, CT 06511.
Priti KumarDepartment of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520.
William L JorgensenDepartment of Chemistry, Yale University, New Haven, CT 06520-8107 william.jorgensen@yale.edu.ORCID 0000-0002-3993-9520
Karen S AndersonDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066.

Funding

Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
In vivo genomic editing of hematopoietic cells for HIV resistanceR01AI112443 · NIAID · YALE UNIVERSITY · PI GLAZER, PETER M, KUMAR, PRITI · 2014 to 2017
$2.1M
NIAID NIH HHS R01 AI112443NIGMS NIH HHS T32 GM007223
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HIV-1HIV InfectionsAnimalsAnti-HIV AgentsDisease Models, AnimalMiceAnti-HIV Agents

Identifiers

PMID30097540
PMCPMC6126721

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.